COMMUNIQUÉS West-GlobeNewswire

Seer Reports Second Quarter 2024 Financial Results
08/08/2024
Launched STAC in Europe and additional customer papers published in leading journals REDWOOD CITY, Calif., Aug. 08, 2024 (GLOBE NEWSWIRE) -- Seer, Inc. (Nasdaq: SEER), a leading life sciences company commercializing a [...]
ALX Oncology Reports Second Quarter 2024 Financial Results and Provides Corporate Update
08/08/2024
SOUTH SAN FRANCISCO, Calif., Aug. 08, 2024 (GLOBE NEWSWIRE) -- ALX Oncology Holdings Inc., (“ALX Oncology” or “the Company”) (Nasdaq: ALXO), an immuno-oncology company developing therapies that block the CD47 immune [...]
Iridex Reports Second Quarter 2024 Financial Results
08/08/2024
MOUNTAIN VIEW, Calif., Aug. 08, 2024 (GLOBE NEWSWIRE) -- Iridex Corporation (Nasdaq: IRIX), a worldwide leader providing innovative and versatile laser-based medical systems, delivery devices, and procedure probes for [...]
Greg Horn Honored with NBJ Lifetime Achievement Award For Transformative Impact on Health and Wellness
07/08/2024
RANCHO PALOS VERDES, Calif., Aug. 07, 2024 (GLOBE NEWSWIRE) -- The Nutrition Business Journal (NBJ) honored Greg Horn with the prestigious NBJ Lifetime Achievement Award at the NBJ Summit on July 31. Presented in front [...]
Context Therapeutics Reports Second Quarter 2024 Operating and Financial Results
07/08/2024
Announced acquisition of CT-95, a mesothelin x CD3 bispecific antibody Claudio Dansky Ullmann, M.D. named Chief Medical Officer Cash and cash equivalents of $101.5 million as of June 30, 2024 PHILADELPHIA, Aug. 07, 2024 [...]
Bioventus to Present at the Canaccord Genuity 44th Annual Global Growth Conference
07/08/2024
DURHAM, N.C., Aug. 07, 2024 (GLOBE NEWSWIRE) -- Bioventus Inc. (Nasdaq: BVS), a global leader in innovations for active healing, today announced that Mark Singleton, senior vice president and chief financial officer, [...]
Health Catalyst Reports Second Quarter 2024 Results
07/08/2024
SALT LAKE CITY, Aug. 07, 2024 (GLOBE NEWSWIRE) -- Health Catalyst, Inc. ("Health Catalyst," Nasdaq: HCAT), a leading provider of data and analytics technology and services to healthcare organizations, today reported [...]
Catalyst Pharmaceuticals Reports Strong Second Quarter 2024 Financial Results and Provides Corporate Update
07/08/2024
Delivered Robust Revenue Performance, Fueled by Exceptional Commercial Execution and Early Success of the U.S. AGAMREE ® Product Launch Reported Record Q2 2024 Total Revenues of $122.7 Million, Representing a 23.2% YoY [...]
RadNet Reports Second Quarter Financial Results with Record Quarterly Revenue and Adjusted EBITDA(1) and Revises Upwards 2024 Financial Guidance Ranges
07/08/2024
Total Company Revenue increased 13.9% to $459.7 million in the second quarter of 2024 from $403.7 million in the second quarter of 2023; Revenue from the Digital Health reportable segment (inclusive of intersegment [...]
OPKO Health Reports Second Quarter 2024 Business Highlights and Financial Results
07/08/2024
Conference call begins at 4:30 p.m. Eastern time today MIAMI, Aug. 07, 2024 (GLOBE NEWSWIRE) -- OPKO Health, Inc. (NASDAQ: OPK) reports business highlights and financial results for the three and six months ended June [...]
ImmuCell to Announce Unaudited Financial Results for the Quarter Ended June 30, 2024
07/08/2024
Conference Call Scheduled for Wednesday, August 14, 2024 at 9:00 AM ET PORTLAND, Maine, Aug. 07, 2024 (GLOBE NEWSWIRE) -- ImmuCell Corporation (Nasdaq: ICCC) (“ImmuCell” or the “Company”), a growing animal health [...]
Revolution Medicines Reports Second Quarter 2024 Financial Results and Update on Corporate Progress
07/08/2024
Revolution Medicines to hold webcast today at 4:30 p.m. Eastern Time REDWOOD CITY, Calif., Aug. 07, 2024 (GLOBE NEWSWIRE) -- Revolution Medicines, Inc. (Nasdaq: RVMD), a clinical-stage oncology company developing [...]
Jushi Holdings Inc. Reports Second Quarter 2024 Financial Results
07/08/2024
Margin Growth with Gross Profit and Gross Margin Reaching $32.6 Million and 50.4% , Respectively Net Loss of $1.9 Million , Compared to $14.0 Million in Q2 2023 Grew Adjusted EBITDA and Adjusted EBITDA Margin to $14.5 [...]
Lyell Immunopharma Reports Business Highlights and Financial Results for the Second Quarter 2024
07/08/2024
Reported dose-dependent antitumor clinical activity in patients with relapsed/refractory triple-negative breast cancer from the Phase 1 trial of LYL797, a ROR1-targeted Chimeric Antigen Receptor (CAR) T‑cell product [...]
Telesis Bio Reports Second Quarter and First Half 2024 Financial Results
07/08/2024
SAN DIEGO, Aug. 07, 2024 (GLOBE NEWSWIRE) -- Telesis Bio Inc. (NASDAQ: TBIO), a leading provider of RNA and DNA solutions enabling researchers to accelerate therapeutic discovery through advanced, flexible, and rapid [...]
LifeMD Reports Second Quarter 2024 Results
07/08/2024
Revenue increased 41% year-over-year to $50.7 million with telehealth revenue up 67% Telehealth achieved standalone profitability one quarter ahead of guidance, with adjusted EBITDA of $820,000 Weight management [...]
Cartesian Therapeutics Announces New Employment Inducement Grants
07/08/2024
GAITHERSBURG, Md., Aug. 07, 2024 (GLOBE NEWSWIRE) -- Cartesian Therapeutics, Inc. (NASDAQ: RNAC) (the “Company”), a clinical-stage biotechnology company developing mRNA cell therapies for the treatment of autoimmune [...]
ICU Medical Announces Second Quarter 2024 Results and Updates Its Fiscal Year 2024 Guidance
07/08/2024
SAN CLEMENTE, Calif., Aug. 07, 2024 (GLOBE NEWSWIRE) -- ICU Medical, Inc. (Nasdaq:ICUI), a leader in the development, manufacture and sale of innovative medical products, today announced financial results for the [...]
Silk Road Medical Reports Second Quarter 2024 Financial Results
07/08/2024
SUNNYVALE, Calif., Aug. 07, 2024 (GLOBE NEWSWIRE) -- Silk Road Medical, Inc. (Nasdaq: SILK), a company focused on reducing the risk of stroke and its devastating impact, today reported financial results for the three [...]

Pages